Health Catalyst

Forecast & Rating6 analysts currently cover Health Catalyst, with about 16.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $1.83, about 0.8% upside from the current price of $1.81. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 16.5% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Health Catalyst's outlook. Data as of Aug 20, 2026; for reference only and not investment advice.